Allergan's Big Deal: A Buyout, Not A Split, Appeases Wary Investors

 
• By Mandy Jackson

Allergan was expected to announce soon that it would follow its shareholders' advice and split the company in two, but it's being acquired by AbbVie for $63bn instead, finally giving investors a big boost in their Allergan holdings after years of decline.

merger and acquisition business concepts, join company on puzzle pieces, 3d rendering
A merger was the answer to Allergan's woes, not a split. • Source: Shutterstock

More from Deals

More from Business